← FDA Drug Approvals (Drugs@FDA)
THIOTEPA
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HIKMA · Approved 2023-09-05
Drug application
- FDA Application #
ANDA211755- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- THIOTEPA
- Generic name
- THIOTEPA
- Active ingredients
- THIOTEPA
- Dosage form
- POWDER
- Route
- INTRACAVITARY, INTRAVENOUS, INTRAVESICAL
- Marketing status
- Prescription
- Sponsor
- HIKMA
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- First approval
- 2023-09-05
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown